Corcept Therapeutics, Inc. (CORT)
84.36
+1.38
(+1.66%)
USD |
NASDAQ |
Dec 09, 14:55
Corcept Therapeutics Total Liabilities (Quarterly): 191.70M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 80.52B |
| Gilead Sciences, Inc. | 37.08B |
| LeMaitre Vascular, Inc. | 219.15M |
| United Therapeutics Corp. | 760.90M |
| Vertex Pharmaceuticals, Inc. | 7.544B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 823.61M |
| Shareholders Equity (Quarterly) | 631.90M |
| Debt to Equity Ratio | 0.0101 |
| Current Ratio | 3.141 |
| Net Debt Paydown Yield | -0.00% |